138 related articles for article (PubMed ID: 12904082)
1. New potential uroselective NO-donor alpha1-antagonists.
Boschi D; Tron GC; Di Stilo A; Fruttero R; Gasco A; Poggesi E; Motta G; Leonardi A
J Med Chem; 2003 Aug; 46(17):3762-5. PubMed ID: 12904082
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.
Quaglia W; Pigini M; Piergentili A; Giannella M; Marucci G; Poggesi E; Leonardi A; Melchiorre C
J Med Chem; 1999 Jul; 42(15):2961-8. PubMed ID: 10425105
[TBL] [Abstract][Full Text] [Related]
3. 1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
Brasili L; Sorbi C; Franchini S; Manicardi M; Angeli P; Marucci G; Leonardi A; Poggesi E
J Med Chem; 2003 Apr; 46(8):1504-11. PubMed ID: 12672251
[TBL] [Abstract][Full Text] [Related]
4. Alpha1-adrenoceptor antagonists. 6. Structural optimization of pyridazinone-arylpiperazines. Study of the influence on affinity and selectivity of cyclic substituents at the pyridazinone ring and alkoxy groups at the arylpiperazine moiety.
Betti L; Corelli F; Floridi M; Giannaccini G; Maccari L; Manetti F; Strappaghetti G; Botta M
J Med Chem; 2003 Jul; 46(16):3555-8. PubMed ID: 12877594
[TBL] [Abstract][Full Text] [Related]
5. Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.
Rosini M; Antonello A; Cavalli A; Bolognesi ML; Minarini A; Marucci G; Poggesi E; Leonardi A; Melchiorre C
J Med Chem; 2003 Nov; 46(23):4895-903. PubMed ID: 14584940
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
Bolognesi ML; Budriesi R; Chiarini A; Poggesi E; Leonardi A; Melchiorre C
J Med Chem; 1998 Nov; 41(24):4844-53. PubMed ID: 9822553
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
[TBL] [Abstract][Full Text] [Related]
8. Novel adrenoceptor antagonists with a tricyclic pyrrolodipyridazine skeleton.
Barlocco D; Cignarella G; Montesano F; Leonardi A; Mella M; Toma L
J Med Chem; 1999 Jan; 42(1):173-7. PubMed ID: 9888842
[TBL] [Abstract][Full Text] [Related]
9. WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
Bolognesi ML; Budriesi R; Cavalli A; Chiarini A; Gotti R; Leonardi A; Minarini A; Poggesi E; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
J Med Chem; 1999 Oct; 42(20):4214-24. PubMed ID: 10514291
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.
Quaglia W; Pigini M; Piergentili A; Giannella M; Gentili F; Marucci G; Carrieri A; Carotti A; Poggesi E; Leonardi A; Melchiorre C
J Med Chem; 2002 Apr; 45(8):1633-43. PubMed ID: 11931617
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, absolute configuration, and biological profile of the enantiomers of trans-[2-(2,6-dimethoxyphenoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (mephendioxan), a potent competitive alpha 1A-adrenoreceptor antagonist.
Quaglia W; Pigini M; Tayebati SK; Piergentili A; Giannella M; Leonardi A; Taddei C; Melchiorre C
J Med Chem; 1996 May; 39(11):2253-8. PubMed ID: 8667368
[TBL] [Abstract][Full Text] [Related]
12. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.
Nagarathnam D; Wetzel JM; Miao SW; Marzabadi MR; Chiu G; Wong WC; Hong X; Fang J; Forray C; Branchek TA; Heydorn WE; Chang RS; Broten T; Schorn TW; Gluchowski C
J Med Chem; 1998 Dec; 41(26):5320-33. PubMed ID: 9857099
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-affinity relationship investigations of 5-heteroaryl-substituted analogues of the antipsychotic sertindole. A new class of highly selective alpha(1) adrenoceptor antagonists.
Balle T; Perregaard J; Ramirez MT; Larsen AK; Søby KK; Liljefors T; Andersen K
J Med Chem; 2003 Jan; 46(2):265-83. PubMed ID: 12519065
[TBL] [Abstract][Full Text] [Related]
15. Region and age dependent differences in alpha(1)-adrenergic responsiveness of rat seminal vesicle and vas deferens.
Yono M; Latifpour J; Yamamoto Y; Imanishi A; Yoshida M
Eur J Pharmacol; 2008 Jun; 587(1-3):291-5. PubMed ID: 18472093
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and alpha(1)-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin.
Sagratini G; Angeli P; Buccioni M; Gulini U; Marucci G; Melchiorre C; Leonardi A; Poggesi E; Giardinà D
Bioorg Med Chem; 2007 Mar; 15(6):2334-45. PubMed ID: 17276073
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin- 1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B- adrenoceptor antagonist.
Giardinà D; Crucianelli M; Romanelli R; Leonardi A; Poggesi E; Melchiorre C
J Med Chem; 1996 Nov; 39(23):4602-7. PubMed ID: 8917649
[TBL] [Abstract][Full Text] [Related]
18. Isoxazolo-[3,4-d]-pyridazin-7-(6H)-ones and their corresponding 4,5-disubstituted-3-(2H)-pyridazinone analogues as new substrates for alpha1-adrenoceptor selective antagonists: synthesis, modeling, and binding studies.
Montesano F; Barlocco D; Dal Piaz V; Leonardi A; Poggesi E; Fanelli F; De Benedetti PG
Bioorg Med Chem; 1998 Jul; 6(7):925-35. PubMed ID: 9730228
[TBL] [Abstract][Full Text] [Related]
19. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A
Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913
[TBL] [Abstract][Full Text] [Related]
20. Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.
Barlocco D; Cignarella G; Piaz VD; Giovannoni MP; De Benedetti PG; Fanelli F; Montesano F; Poggesi E; Leonardi A
J Med Chem; 2001 Jul; 44(15):2403-10. PubMed ID: 11448222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
